Evaluation of the Heparin Binding Protein Levels in Sepsis
Status: | Completed |
---|---|
Conditions: | Infectious Disease, Hospital |
Therapuetic Areas: | Immunology / Infectious Diseases, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 9/27/2017 |
Start Date: | July 2015 |
End Date: | July 2017 |
Heparin Binding Protein (HBP) in Sepsis for the Prediction of Disease Progression
Present criteria used to define sepsis are non-specific, making it difficult to both
distinguish sepsis from other diseases and to predict which patients are likely to become
more severely ill. In standard care, patients at risk of becoming more severely ill are
neither identified nor indicated for resuscitative efforts until they develop hemodynamic
insufficiency or organ failure; after progression to severe disease, mortality increases
significantly. The identification of risk patients can lead to earlier initiation of
resuscitation therapies and potentially lead to reduced morbidity and mortality. This study
aims to determine whether Heparin-binding protein (HBP), which is secreted from neutrophils
during infection and a mediator of vascular leakage, can act as a biomarker for the
progression to severe sepsis with circulatory failure.
The objective of this study is to validate the utility of HBP to predict the development of
delayed onset organ dysfunction in sepsis in patients and to compare the performance of HBP
relative to currently used prognostic biomarkers in sepsis.
distinguish sepsis from other diseases and to predict which patients are likely to become
more severely ill. In standard care, patients at risk of becoming more severely ill are
neither identified nor indicated for resuscitative efforts until they develop hemodynamic
insufficiency or organ failure; after progression to severe disease, mortality increases
significantly. The identification of risk patients can lead to earlier initiation of
resuscitation therapies and potentially lead to reduced morbidity and mortality. This study
aims to determine whether Heparin-binding protein (HBP), which is secreted from neutrophils
during infection and a mediator of vascular leakage, can act as a biomarker for the
progression to severe sepsis with circulatory failure.
The objective of this study is to validate the utility of HBP to predict the development of
delayed onset organ dysfunction in sepsis in patients and to compare the performance of HBP
relative to currently used prognostic biomarkers in sepsis.
Sepsis is a heterogeneous disorder caused by an invasive infection that results in host
inflammatory response. The underlying pathogenesis is complex and dependent on the etiologic
microorganism, site of infection, and host factors. Present criteria defining sepsis
(including change of body temperature, increased heart and respiration rates, and
leukocytosis/leukopenia) are non-specific making it difficult to distinguish sepsis from
other diseases and in particular to predict which patients are likely to become more severely
ill. The consensus definition of sepsis has been debated over the past years and one
suggested approach is to focus more on the presence of organ dysfunction. In standard care,
patients at risk of becoming more seriously ill are not identified nor indicated for
resuscitative efforts until they develop hemodynamic insufficiency or organ failure. However,
after progression to severe disease mortality increases significantly. A recent study showed
that almost a quarter of patients presenting with uncomplicated sepsis in an Emergency
Department (ED) developed severe sepsis or septic shock within 72 hours. Delayed in-hospital
progression to increased organ dysfunction was associated with increased transfer to the
intensive care unit (ICU) and increased hospital length of stay. The identification of risk
patients can lead to earlier initiation of resuscitation therapies and potentially lead to
reduced morbidity and mortality. There are also increasing evidence that a single episode of
severe sepsis has negative impact on quality of life and mortality several years after the
actual incident. Also, recent studies indicate that less severe organ dysfunction, such as
small increases in serum creatinine, are associated with increased long-term mortality among
sepsis survivors.
Mechanisms that trigger the release of heparin-binding protein (HBP) from neutrophils in the
presence of bacteria have previously been reported. HBP has several functions such as a
chemo-attractant and as an activator of monocytes and macrophages. Also, it induces vascular
leakage by interacting with the capillary endothelium and breaking cell barriers. In vivo
studies have demonstrated that HBP released by the complex formed by the group A
streptococcal M1 protein and fibrinogen induces a massive tissue edema contributing to severe
organ damage. In clinical investigations, the release of HBP has been demonstrated in various
infectious diseases caused by a wide array of bacteria. A recent single-center study of
patients admitted for suspected infection and fever showed that plasma levels of HBP were
significantly higher among patients who presented with or developed severe sepsis with
circulatory failure.
A prospective observational study in a tertiary care Emergency Department. Patients must be
identified and enrolled within 72 hours of qualifying inclusion criteria. At this time,
unused blood samples collected for routine testing will be examined and the plasma level of
HBP will be recorded; only blood samples processed by the lab within 3 hours of collection
will be used. In addition, physiologic variables detailed in the data elements section,
including mental status, metabolic, renal, heme, hepatic, respiratory, cardiovascular,
resuscitation, and vasopressor use will be recorded. Patients who meet the inclusion criteria
will be identified. Researchers will collect and record a resuscitation summary for a span of
4 hours; this data, outlined in the data elements section, will be linked to the quality
improvement (QI) database of Sepsis Research. Additionally, the patient's HBP plasma levels
will be measured from unused blood samples collected for routine lab testing time (T) 24, 48,
and 72-hours (T24, T48, T72) after meeting the inclusion criteria (T0); resuscitation
summaries will also be collected at T24, T48, T72. For patients meeting sepsis alert
criteria, T0 will be defined as the time that the patient qualified; those enrolled based on
Predisposition, Injury, Response, Organ dysfunction (PIRO) score will have T0 defined as the
time hospital admission was ordered. Patients will be followed throughout their time in the
hospital and their outcomes will be recorded.
inflammatory response. The underlying pathogenesis is complex and dependent on the etiologic
microorganism, site of infection, and host factors. Present criteria defining sepsis
(including change of body temperature, increased heart and respiration rates, and
leukocytosis/leukopenia) are non-specific making it difficult to distinguish sepsis from
other diseases and in particular to predict which patients are likely to become more severely
ill. The consensus definition of sepsis has been debated over the past years and one
suggested approach is to focus more on the presence of organ dysfunction. In standard care,
patients at risk of becoming more seriously ill are not identified nor indicated for
resuscitative efforts until they develop hemodynamic insufficiency or organ failure. However,
after progression to severe disease mortality increases significantly. A recent study showed
that almost a quarter of patients presenting with uncomplicated sepsis in an Emergency
Department (ED) developed severe sepsis or septic shock within 72 hours. Delayed in-hospital
progression to increased organ dysfunction was associated with increased transfer to the
intensive care unit (ICU) and increased hospital length of stay. The identification of risk
patients can lead to earlier initiation of resuscitation therapies and potentially lead to
reduced morbidity and mortality. There are also increasing evidence that a single episode of
severe sepsis has negative impact on quality of life and mortality several years after the
actual incident. Also, recent studies indicate that less severe organ dysfunction, such as
small increases in serum creatinine, are associated with increased long-term mortality among
sepsis survivors.
Mechanisms that trigger the release of heparin-binding protein (HBP) from neutrophils in the
presence of bacteria have previously been reported. HBP has several functions such as a
chemo-attractant and as an activator of monocytes and macrophages. Also, it induces vascular
leakage by interacting with the capillary endothelium and breaking cell barriers. In vivo
studies have demonstrated that HBP released by the complex formed by the group A
streptococcal M1 protein and fibrinogen induces a massive tissue edema contributing to severe
organ damage. In clinical investigations, the release of HBP has been demonstrated in various
infectious diseases caused by a wide array of bacteria. A recent single-center study of
patients admitted for suspected infection and fever showed that plasma levels of HBP were
significantly higher among patients who presented with or developed severe sepsis with
circulatory failure.
A prospective observational study in a tertiary care Emergency Department. Patients must be
identified and enrolled within 72 hours of qualifying inclusion criteria. At this time,
unused blood samples collected for routine testing will be examined and the plasma level of
HBP will be recorded; only blood samples processed by the lab within 3 hours of collection
will be used. In addition, physiologic variables detailed in the data elements section,
including mental status, metabolic, renal, heme, hepatic, respiratory, cardiovascular,
resuscitation, and vasopressor use will be recorded. Patients who meet the inclusion criteria
will be identified. Researchers will collect and record a resuscitation summary for a span of
4 hours; this data, outlined in the data elements section, will be linked to the quality
improvement (QI) database of Sepsis Research. Additionally, the patient's HBP plasma levels
will be measured from unused blood samples collected for routine lab testing time (T) 24, 48,
and 72-hours (T24, T48, T72) after meeting the inclusion criteria (T0); resuscitation
summaries will also be collected at T24, T48, T72. For patients meeting sepsis alert
criteria, T0 will be defined as the time that the patient qualified; those enrolled based on
Predisposition, Injury, Response, Organ dysfunction (PIRO) score will have T0 defined as the
time hospital admission was ordered. Patients will be followed throughout their time in the
hospital and their outcomes will be recorded.
Inclusion Criteria:
- Clinical diagnosis of a bacterial or viral infection
- 18 years or older
- Meet the sepsis alert criterion (Hypotension (BP < 90 after 2 L of fluids or lactate ≥
4) OR
- PIRO (Predispose, Infection, Response, Organ dysfunction ) score ≥ 15 .
Exclusion Criteria:
- Minors (less than 18 years of age)
- Patients who do not meet sepsis criteria as described above
We found this trial at
1
site
Newark, Delaware 19713
Principal Investigator: Ryan C Arnold, MD
Phone: 302-733-1542
Click here to add this to my saved trials